RxDoctor Payments Data

Anthony Katz, MD

Family Medicine · Phoenix, AZNPI 1104865922

Payments from drug & device makers

$9,687in general payments, 2019–2025

Across 584 payments — averaging $16.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • AstraZeneca$868
  • Pfizer$774
  • Boehringer Ingelheim$461
  • Novo Nordisk$439
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$371
  • plus $4K from 54 others

What the payments were for

  • Food & beverage$9,687100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)181$2,375
AstraZeneca34$868
Pfizer51$774
Boehringer Ingelheim23$461
Novo Nordisk28$439
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC25$371
Takeda Pharmaceuticals U.S.A., Inc.25$363
Lilly USA, LLC21$338
Astellas Pharma US Inc15$320
Abbott14$292
GSK15$251
Exact Sciences9$190
Johnson & Johnson9$169
Otsuka America Pharmaceutical, Inc.7$148
Almatica Pharma LLC5$145
Axsome Therapeutics, Inc.7$138
Amgen(2 entities)8$134
Novartis7$128
Merck9$116
Shield Therapeutics Inc5$112
Dexcom, Inc.5$110
Lundbeck LLC6$105
Bayer6$87
Idorsia Pharmaceuticals US Inc5$84
Currax Pharmaceuticals LLC5$73
Impel Pharmaceuticals Inc.3$68
Amarin Pharma, Inc.4$66
Boston Scientific3$61
Kowa Pharmaceuticals America, Inc.3$61
Aimmune Therapeutics, Inc.3$59
Vanda Pharmaceuticals Inc.3$53
Teva Pharmaceuticals USA, Inc.2$51
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)3$48
E.r. Squibb & Sons, L.L.C.2$44
Eisai Inc.2$38
Alfasigma USA, Inc.2$37
Hologic Sales And Service, LLC1$36
Saluda Medical Americas, Inc.1$33
Therapeuticsmd, Inc.2$32
Scilex Pharmaceuticals Inc.2$31
Acella Pharmaceuticals, LLC2$30
Mayne Pharma Commercial LLC1$29
Edwards Lifesciences1$24
Si-bone, Inc.1$22
Phadia US Inc.1$22
IBSA Pharma Inc.1$20
Medtronic1$18
Tonix Medicines, Inc.1$17
Halozyme Inc1$17
Genentech USA, Inc.1$16
Biohaven Pharmaceutical Holding Company Ltd.1$16
Tolmar, Inc.1$15
Lucid Diagnostics Inc.1$15
Nalu Medical, Inc.1$15
Daiichi Sankyo Inc.1$14
Bausch Health US, LLC1$14
Ironshore Pharmaceuticals Inc.1$14
Nevro Corp.1$14
Arbor Pharmaceuticals, Inc.1$13
Cranial Technologies, Inc1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,687 in reported general payments places this provider in the 90th percentile of 2,099 family medicine providers in Arizona.

See all family medicine providers in Arizona

Medicare billing

Part B allowed, 2024
$220,517
Medicare patients
852
Services billed
2,889

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban99$75,620
SymtuzaDarunavir/Cob/Emtri/Tenof Alaf12$64,654
JardianceEmpagliflozin59$61,766
FarxigaDapagliflozin Propanediol37$36,015
XareltoRivaroxaban32$34,945
MyrbetriqMirabegron49$31,518
VraylarCariprazine Hcl20$30,776
OzempicSemaglutide18$29,319
TrulicityDulaglutide20$25,481
JanuviaSitagliptin Phosphate15$22,995
MounjaroTirzepatide14$17,157
JanumetSitagliptin Phos/Metformin Hcl18$16,378
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog18$8,820
Xtampza ErOxycodone Myristate14$8,596
SynthroidLevothyroxine Sodium86$8,206

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Premarin$774$79,066118 claims
Boehringer IngelheimJardiance$461$61,76659 claims
Lilly USA, LLCTrulicity, Mounjaro$338$42,63734 claims
MerckJanuvia, Janumet$116$39,37333 claims
AbbVieVraylar, Synthroid$2,375$38,982106 claims
AstraZenecaFarxiga$868$36,01537 claims
Johnson & JohnsonXarelto$169$34,94532 claims
Astellas Pharma US IncMyrbetriq$320$31,51849 claims
Novo NordiskOzempic$439$29,31918 claims
GSKArnuity Ellipta$251$3,92215 claims
Almatica Pharma LLCSertraline Hcl$145$2,315351 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,099 family medicine providers in Arizona.

Other family medicine in Phoenix

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →